Clinical Trial Update: Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update comparing the pharmacokinetics and pharmacodynamics of FMXIN002 versus EpiPen in healthy adults with allergic rhinitis across Phase 1 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Anaphylaxis

Drugs mentioned

• EpiPen (epinephrine)
• FMXIN002

Snippet

Sponsor: Nasus Pharma | Conditions: Anaphylaxis, Allergy | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION